Edition: India  
 
> >

Austrialian students recreate Martin Shkreli price-hike drug

euronews Friday, 2 December 2016
The man who became a global figure of greed after hiking the price of a life-saving drug by 5000 percent in the US, may have just met his match.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 
Source: Guardian - < > Embed

News video: Sydney students recreate life-saving drug that had 5,000% price hike – video

Sydney students recreate life-saving drug that had 5,000% price hike – video 00:50

A group of students have managed to create a drug in their school laboratory that had its price controversially increased from US$13.50 to US$750 a tablet by former hedge fund manager Martin Shkreli. The Sydney Grammar students reproduced the drug, Daraprim, which is used to treat a rare but deadly...

You Might Like


Other recent news in Front Page

J&K: Normal life paralysed following killing of 3 local LeT terrorists in PULWAMAIraq: ISLAMIC STATE blows up iconic al-Nuri mosque of Mosul
Box office analysis: Will SALMAN KHAN - Kabir Khan's 'Tubelight' be as big as 'Bajrangi Bhaijaan'?Confederations Cup 2017: Cristiano Ronaldo header gives Portugal 1-0 win over hosts RUSSIA
Exclusive: Check out these stills of Athiya Shetty and ANIL KAPOOR from 'Mubarakan' title track!ONEPLUS 5 to launch in India today: Here’s how to watch the live stream
Trump's top aide KENNETH JUSTER to be USA's new ambassador to IndiaRAJIV GAUBA to be next Union home secretary
Queen's speech indicates THERESA MAY will listen harder on Brexit concernsSAUDI KING empowers young reformer son in succession shake-up

Twitter

Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2017 newsR / One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter